Pitt Shield

Magnetic Resonance-Guided Focused Ultrasound Capsulotomy for Treatment-Resistant Psychiatric Disorders.

Authors: Davidson B, Hamani C, Huang Y, Jones RM, Meng Y, Giacobbe P, Lipsman N

Psychiatric surgery is an important domain of functional neurosurgery and involves deep brain stimulation (DBS) or lesional procedures performed for treatment-resistant psychiatric illness. It has recently become possible to use magnetic-guided focused ultrasound (MRgFUS) to perform bilateral capsulotomy, a lesional technique commonly carried out with surgical radiofrequency ablation or stereotactic radiosurgery. MRgFUS offers several advantages, including improved safety and real-time imaging of the lesions. To describe the clinical and technical aspects of performing bilateral MRgFUS capsulotomy in patients with severe refractory depression and obsessive-compulsive disorder. We describe the clinical and technical considerations of performing MRgFUS capsulotomy. Topics discussed include patient selection, headframe application, targeting, sonication strategies, and follow-up procedures. MRgFUS capsulotomy was performed in 16 patients without serious clinical or radiographic adverse events. MRgFUS allows for a safe, less invasive technique for performing a well-studied psychiatric surgery procedure-the anterior capsulotomy.

Introduction

Purpose Thermal ablation
Study Objective To assess the safety and efficacy of magnetic resonance-guided focused ultrasound capsulotomy for treating treatment-resistant psychiatric disorders.
Disease model obsessive-compulsive disorder; major depressive disorder
MRI or image guidance method Magnetic Resonance-guided (MRI-guided)
Targeted brain region(s) internal capsule

Outcomes and Safety

Summary of Outcomes MRgFUS capsulotomy targeting the anterior limb of the internal capsule significantly reduced psychiatric symptoms (OCD and MDD) in treatment-resistant patients
Duration of biological effect not reported
Safety-related matter The procedure was generally safe and well-tolerated; transient adverse effects included headache and fatigue, with no serious persistent neurological deficits reported.

Brain Region

Ultrasound Parameters

Ultrasound instrument Exablate Neuro 4000 (Insightec)
FUS Frequency 650 kHz
FUS Intensity not reported
FUS Pressure not reported
FUS Mode not reported
Pulse duration not reported
Duration of a single FUS session 20s

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search